Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2010 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 19 | Q2 2024 | 21.0% |
MATINAS BIOPHARMA HLDGS INC | 17 | Q1 2022 | 0.0% |
CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q2 2024 | 0.2% |
LIBERTY LATIN AMERICA LTD | 15 | Q2 2024 | 4.6% |
METAURUS EQUITY COMPONENT TR | 15 | Q4 2021 | 1.3% |
PRECIGEN INC | 15 | Q2 2022 | 2.5% |
SPDR GOLD TRUST | 14 | Q1 2024 | 78.4% |
SPDR S&P 500 ETF TR | 14 | Q2 2024 | 61.3% |
BIOMERICA INC | 14 | Q2 2024 | 0.3% |
METAURUS US EQUITY EX DIV | 13 | Q3 2021 | 8.6% |
View Fore Capital, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-29 |
13F-HR | 2024-08-07 |
13F-HR | 2024-05-07 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-09 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-08 |
View Fore Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.